05:58 PM EDT, 03/12/2026 (MT Newswires) -- Oncology Institute ( TOI ) reported a Q4 loss late Thursday of $0.06 per diluted share, narrowing from the loss of $0.14 a year earlier.

Four analysts polled by FactSet expected a loss of $0.09.

Revenue for the three months ended Dec. 31 rose to $142 million from $100.3 million a year earlier.

Four analysts expected $139.8 million.

The company expects full-year 2026 revenue of $630 million to $650 million.

Four analysts project $636.2 million.

Oncology Institute ( TOI ) shares rose 13% in after-hours trading.